← The Lantern · New Carlisle
health · class ii

Microbiologics Inc recalls KWIK-STIK and LYFO DISK, quality control kit for culture media Catalog # 0805K…

The stated reason: Affected products contain Staphylococcus epidermidis instead of the expected Brevundimonas diminuta.

Illustration: a pharmacy counter with pill bottles, a blister pack and one bottle set aside
Illustration · The Lantern

Microbiologics Inc began a medical device recall on June 17, 2025 whose reported distribution included Ohio. FDA

What the record shows

This may cause the user's quality control to fail and delayed diagnosis for the patient. FDA graded it Class II — use may cause temporary or medically reversible health consequences. Quantity affected: 21 total. The recall is listed as ongoing. FDA

1 source

Context

This is one of 11 records of this type (Class Ii) from this source in the year preceding it. FDA

The Lantern holds 60 records from this source in total, and 2883 for New Carlisle across every source. FDA

1 source

By the numbers

  • Date of record: June 17, 2025 FDA
  • Recall number: Z-2124-2025 FDA
  • Recalls in this action: 1 FDA
  • Recalling firm: Microbiologics Inc FDA
  • Product: KWIK-STIK and LYFO DISK, quality control kit for culture media Catalog # 0805K and 0805L FDA
  • Reason for recall: Affected products contain Staphylococcus epidermidis instead of the expected Brevundimonas diminuta. This may cause… FDA
1 source
How we know this:

Assembled mechanically from the source filing and The Lantern's own record database — no AI-written prose. Every figure above appears verbatim in the cited record, which is linked on this page. FDA

The source filing

Recall numberZ-2124-2025
Recalls in this action1
Recalling firmMicrobiologics Inc
ProductKWIK-STIK and LYFO DISK, quality control kit for culture media Catalog # 0805K and 0805L
Reason for recallAffected products contain Staphylococcus epidermidis instead of the expected Brevundimonas diminuta. This may cause the user's quality control to fail and delayed diagnosis for the patient.
ClassificationClass II — use may cause temporary or medically reversible health consequences
Recall typemedical device
Quantity21 total
StatusOngoing
Voluntary or mandatedVoluntary: Firm initiated
Initiated20250617
Reported20250723
DistributionUS distribution to states of: Utah and Ohio; and OUS (International) to countries of: Italy, Netherlands, Argentina, Korea, Jordan, Spain, and Bangladesh.
Firm locationSaint Cloud, MN, United States
View the original at fda.gov

Published by U.S. Food and Drug Administration (openFDA). This is the agency's public filing as The Lantern received it, shown with its fields named in plain English.

More from Clark County, OHWatch records like this
“Oh, No!” Have we made an error? Report it to us here! We are eager to correct the record.